Agaricus blazei is a medically important mushroom widely eaten and prescribed around the world. It is belonged to the Agaricaceae family and is popularly known as "Himematsutake" in Japan. In Brazil, this mushroom is used as a traditional medicine for the prevention of cancer, diabetes, hyperlipidemia, arteriosclerosis, and chronic hepatitis. Recently, it has been reported that Agaricus blazei has the anti-tumor, immunomodulatory, anti-mutagenic, anti-oxidant, and anti-bacterial activities.
Inhibitory Effects of Agaricus blazei on Mast Cell-Mediated AnaphylaxisLike Reactions
yielded 11.5 g dried powder and kept at Ϫ20°C until use. The dried extract was dissolved in saline or HEPES-Tyrode buffer (136 mM NaCl, 5 mM KCl, 2 mM CaCl 2 , 11 mM NaHCO 3 , 0.6 mM NaH 2 PO 4 , 2.75 mM MgCl 2 , 5.4 mM HEPES, 1.0 mg/ml BSA, 1.0 mg/ml glucose, 0.1 mg/ml heparin, pH 7.4) before use.
Compound 48/80-Induced Systemic Anaphylaxis-Like Reaction Mice (nϭ10/group) were intraperitoneally received compound 48/80 [8 mg/kg body weight (BW)] as described previously. 10) ABWE or DSCG (0.01 to 1 g/kg BW) was dissolved in saline and orally administered 24, 12 and 1 h before the injection of compound 48/80. Mortality was monitored for 1 h after the induction of anaphylactic shock.
Compound 48/80-Induced Ear Swelling Response Ear swelling response was investigated by the method described previously. 11) Compound 48/80 was freshly dissolved in saline (5 mg/ml) and intradermally injected in the ventral aspect of the left side of mouse ear (100 mg/site, 20 ml) using a 30-gauge hypodermic needle. Sham saline was intradermally injected in the ventral aspect of the right side of mouse ear. Ear thickness was measured with a digital micrometer (Mitutoyo, No. 7326, Japan) under mild anesthesia induced by the intraperitoneal injection of 1 : 1 mixture (50 ml) of ketamin (1 mg/ml) and xylazine hydrochloride (23.32 mg/ml). Mice were kept in immobility state during the measurement. Ear swelling response represented an increment in thickness above baseline control values. Ear swelling response was determined 1 h after the injection of compound 48/80 or vehicle. ABWE (0.01 to 1 g/kg BW) was orally administered 24, 12 and 1 h before the injection of compound 48/80.
Compound 48/80-Induced or Anti-Dinitrophenyl (DNP) IgE-Mediated Passive Cutaneous Anaphylaxis (PCA)-Like Reaction After the intradermal injection of 0.5 mg/20 ml compound 48/80 in the dorsal skin of each mouse, 2% Evans blue solution was intravenously injected into the lateral tail vein of each mouse. The next steps were conducted following the procedures outlined in the next paragraph. Anti-DNP IgE-mediated PCA was examined as reported previously. 12) Mice were sensitized in the right dorsal skin by the intradermal injection of 200 ng anti-DNP IgE in 20 ml phosphate-buffered saline (PBS) and were given a sham PBS injection in the left dorsal skin. Twenty-four hours later, the mice received into the lateral tail vein an injection of 200 ml of PBS containing 100 mg DNP-HSA with 2% Evans blue. ABWE was orally administered 24, 12 and 1 h before the injection of compound 48/80 or challenge.
Thirty minutes after the 2% Evans blue injection or challenge, the mice were killed by terminal anaesthesia, tissue sections around the intradermal injection site excised and weighed, followed by extraction of extravasated Evan's blue dye by incubation of biopsies in 1 ml formamide at 55°C for 24 h and measurement of absorbance at 620 nm using a spectrophotometer (Spectra MAX PLUS, Molecular Devices, CA, U.S.A.). 13) Tissue Evans blue concentrations were quantified by interpolation on a standard curve of dye concentrations in the range of 0.01 to 30 mg/ml.
Preparation of Mast Cell Suspension Rat peritoneal mast cells (RPMC) were isolated as described previously. 14) In brief, rats were anesthetized with ether and injected with 10 ml of calcium-free HEPES-Tyrode buffer into the peritoneal cavity, and the abdomen was gently massaged for about 90 s. The peritoneal cavity was opened, and the fluid was aspirated using a Pasteur pipette, and RPMC were purified by using a percoll density gradient as described in detail elsewhere. 15) RPMC preparations were about 95% pure as assessed by toluidine blue staining and at least 98% of these cells were viable as assessed by trypan blue exclusion. 16) Purified mast cells (1ϫ10 6 cells/ml) were resuspended in HEPES-Tyrode buffer.
Mast Cell Viability Assay To test the viability of cells, the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) colorimetric assay was performed as described previously. 17) Briefly, RPMC (2ϫ10 5 cells/well) were incubated with various concentrations (10-1000 mg/ml) of ABWE at 37°C for 2 h. After addition of MTT (100 mg in 100 ml saline), cells were incubated at 37°C for 1 h. The crystallized MTT was dissolved, and the absorbance was measured at 570 nm with a spectrophotometer.
Assay of Histamine Release RPMC suspensions (2ϫ 10 5 cells in 200 ml) were preincubated with ABWE (10-1000 mg/ml) or DSCG at 37°C for 10 min and then incubated with compound 48/80 (0.25 mg/ml) for 20 min. In addition, RPMC were sensitized with 10 mg/ml anti-DNP IgE for 18 h and preincubated with ABWE or DSCG at 37°C for 10 min prior to challenge with DNP-HSA (100 ng/ml). Following centrifugation at 150ϫg for 10 min at 4°C, the amount of histamine in the supernatant was determined by the radioenzymatic method.
18) The inhibition percentage of histamine release was calculated using the following formula: % inhibitionϭ[(histamine release without ABWEϪ histamine release with ABWE)/histamine release without ABWE]ϫ100.
Measurement of 45
Ca Uptake The calcium uptake of mast cells was measured according to the method described by Chai et al. 19) Purified RPMC were resuspended in HEPES-Tyrode buffer containing 45 Ca (1.5 mCi/ml; 1 Ciϭ 3.7ϫ10 10 becquerels; PerkinElmer Life Sciences, MA, U.S.A.), and incubated at 4°C for 10 min. Mast cell suspensions were preincubated with ABWE (10-1000 mg/ml) at 37°C for 10 min and then incubated with compound 48/80 (0.25 mg/ml) at 37°C for 20 min. The reaction was stopped by the addition of 1 mM lanthanum chloride. The samples were centrifuged 3 times at 150ϫg for 10 min at 4°C, and then RPMC were lysed with 10% Triton X-100 and vigorous shaking. Radioactivity of the solution was measured in a scintillation b-counter (Liquid Scintillation Analyzer, A Canberra Company, Australia).
Measurement of cAMP Level
The cyclic adenosine-3Ј,5Ј monophosphate (cAMP) level was measured by the method described by Holmegaard. 20) In brief, RPMC suspensions were added to an equivalent volume (200 ml) of prewarmed buffer containing ABWE (10-1000 mg/ml) or theophylline (1000 mg/ml) in an Eppendorf tube. The reaction was allowed to proceed for discrete time intervals, terminated by centrifugation at 150ϫg for 10 min at 4°C, and then each sample was added to 250 ml of 50 mM sodium acetate buffer (pH 6.2) under vigorous vortexing, followed by snap frozen in liquid nitrogen. The frozen samples were thawed and vortexed, and then the debris were sedimented by centrifugation at 1200ϫg for 10 min at 4°C. The cAMP level in the supernatant was determined by radioimmunoassay using a Rianen assay system (PerkinElmer Life Sciences, MA, U.S.A.).
Statistical Analysis
The results obtained were expressed as meanϮS.E.M. for the number of experiments. Student's t-test was used for a statistical comparison between groups. Results with pϽ0.05 were considered statistically significant.
RESULTS

Effect of ABWE on Compound 48/80-Induced Systemic Anaphylaxis-Like Reaction
To investigate the effects of ABWE in anaphylactic reactions, we first used an in vivo model of systemic anaphylaxis-like reaction using compound 48/80. After the intraperitoneal injection of compound 48/80 (8 mg/kg BW) into mice, a mortality rate was examined for 1 h. As shown in Table 1 , the injection of compound 48/80 resulted in 100% death of animals. Oral administration of ABWE (0.01 to 1 g/kg BW) reduced the mortality induced by compound 48/80 in a dose-dependent manner. Moreover, DSCG (reference drug) dose-dependently inhibited compoud 48/80-induced mortality.
Effect of ABWE on Compound 48/80-Induced Ear Swelling Response Ear swelling was induced by the injection of compound 48/80 (100 mg/site) as described.
11) Oral administration of ABWE reduced the ear swelling response induced by compound 48/80 in a dose-dependent fashion ( Table 2) .
Effect of ABWE on Compound 48/80-Induced or Anti-DNP IgE-Mediated PCA-Like Reaction It has been previously demonstrated that the intradermal injection of compound 48/80 into the dorsal skin of mice provokes the increase of mast cell-dependent vascular permeability documented by Evans blue extravasation. 21) As shown in Table 3 , oral administration of ABWE dose-dependently reduced the vascular permeability changes induced by compound 48/80. In addition, as described in Materials and Methods, local extravasation was also induced by a local injection of anti-DNP IgE followed by an intravenous antigenic challenge. Oral administration of ABWE dose-dependently inhibited anti-DNP IgE-mediated PCA (Table 4) .
Mast Cell Viability Assay MTT conversion assay was used to determine the viability of RPMC exposed to ABWE. As shown in Fig. 1 , the viable cells were almost 100% after exposure to 1000 mg/ml ABWE for 2 h, and ABWE had no Groups of mice (nϭ10/group) were orally administrated with 300 ml of saline or drugs (ABWE or DSCG) 24, 12 and 1 h before the injection of compound 48/80. The compound 48/80 was intraperitoneally given to the group of mice. Mortality (%) within 1 h following compound 48/80 injection was presented as the number of dead miceϫ100/total number of experimental mice. Groups of mice (nϭ10/group) were orally administrated with 300 ml of saline or ABWE 24, 12 and 1 h before the injection of compound 48/80. Twenty microliters of compound 48/80 (100 mg/site) were injected to the ears of mice. Each value represents the meanϮS.E.M. of three independent experiments. * * * pϽ0.001, significantly different from the saline value. cytotoxicity on RPMC.
Effect of ABWE on Histamine Release from RPMC The effect of ABWE on compound 48/80-induced histamine release from RPMC was shown (Fig. 2) . The histamine release from compound 48/80-treated RPMC was reduced in a dose-dependent manner of ABWE. The histamine release from compound 48/80-treated RPMC after pretreatment of 0, 10, 100, or 1000 mg/ml of ABWE amounted to 2.34Ϯ0.23, 1.71Ϯ0.08, 1.49Ϯ0.09, or 0.99Ϯ0.02 mg/ml, respectively. DSCG also showed a significant inhibition rate. In addition, the inhibitory effect of ABWE on anti-DNP IgE-mediated histamine release from RPMC was shown in Fig. 3 . ABWE dose-dependently inhibited anti-DNP IgE-mediated histamine release from RPMC. These results indicate that ABWE contains the active compounds, which inhibit compound 48/80-induced or IgE-mediated anaphylaxis-like reactions by blocking histamine release from RPMC.
Effect of ABWE on Calcium Uptake into RPMC It is well established that an augmentation of intracellular calcium content by increased calcium uptake into RPMC contributes to histamine release. 22, 23) Thus, we measured calcium uptake. ABWE alone did not affect calcium uptake into RPMC (Fig.  4) . The calcium uptake into RPMC induced by 0, 10, 100, or 1000 mg/ml of ABWE amounted to 44.2Ϯ2.0, 46.8Ϯ1.4, 42.2Ϯ0.3, or 43.7Ϯ2.6 nM, respectively. However, ABWE inhibited compound 48/80-induced calcium uptake into RPMC in a concentration-dependent manner. The calcium uptake into compound 48/80-treated RPMC after pretreatment of 0, 10, 100, or 1000 mg/ml of ABWE amounted to 87.0Ϯ2.3, 75.1Ϯ1.0, 62.2Ϯ1.3, or 57.3Ϯ0.5 nM, respectively. These results suggest that ABWE may inhibit histamine release through blocking calcium uptake into RPMC.
Effect of ABWE on cAMP Level of RPMC To examine whether ABWE exhibits any effects on the compound 48/80-induced reduction of cAMP in RPMC, we also assessed the intracellular cAMP level. Treatment of ABWE increased cAMP level in a dose-dependent fashion. The cAMP level in RPMC induced by 0, 10, 100, or 1000 mg/ml of ABWE amounted to 0.93Ϯ0.01, 1.23Ϯ0.02, 1.35Ϯ0.03, or 1.48Ϯ0.03 pmol/ml, respectively. Treatment of RPMC with compound 48/80 showed a significant decrease in the cAMP level as compared to those treated with buffer only. But ABWE inhibited the compound 48/80-induced cAMP reduction of RPMC in a dose-dependent way (Fig. 5) . The cAMP level in compound 48/80-treated RPMC after pretreatment of 0, 10, 100, or 1000 mg/ml of ABWE amounted to 0.81Ϯ0.02, 1.14Ϯ0.07, 1.30Ϯ0.04, or 1.37Ϯ0.03 pmol/ml, respectively. Theophylline (phosphodiesterase inhibitor) also increased the level of intracellular cAMP and significantly inhibited compound 48/80-induced cAMP reduction in RPMC. These results suggest that ABWE may block histamine release by increasing the cAMP level in RPMC.
DISCUSSION AND CONCLUSIONS
Here we have demonstrated that ABWE pretreatment profoundly attenuates compound 48/80-induced systemic anaphylaxis-like reaction, ear swelling response, and PCA-like reaction in mice. ABWE also inhibits anti-DNP IgE-mediated PCA. ABWE dose-dependently reduces histamine release from RPMC activated by compound 48/80 or anti-DNP IgE. These results suggest that ABWE contains the active compounds to inhibit both compound 48/80-induced anaphylaxis-like reaction and IgE-mediated anaphylactic reaction by blocking histamine release from RPMC.
Stimulation of mast cells with compound 48/80 is believed to initiate the activation of a signal transduction pathway, which leads to histamine release. In general, compound 48/80 initiates the generation of superoxide anion by A-kinase inactivation through decreasing the intracellular cAMP concentration in RPMC. 24 ) Generated superoxide anion results in the inositol 1,4,5-triphosphate (IP 3 ) or GTP-induced calcium release from the endoplasmic reticulum (ER). 25) Accordingly, depletion of intracellular calcium store (ER) activates a calcium influx into RPMC, which leads to the increase of the intracellular calcium content. 26) Consequently, increased intracellular calcium levels cause histamine release from RPMC. 22, 23) Interestingly, treatment of ABWE increases cAMP level beyond the basal level. Although the mechanism of ABWE-induced cAMP production has not been elucidated, ABWE may activate the adenylate cyclase directly or indirectly, otherwise inhibit cAMP phosphodiesterase. In addition, ABWE prevents the compound 48/80-induced cAMP reduction and calcium uptake of RPMC in a dose-dependent fashion. Taken together, ABWE may block the generation of superoxide anion by A-kinase activation through increasing the intracellular cAMP in compound 48/80-treated RPMC. Subsequently, we speculate that decreased superoxide anion as well as increased cAMP impedes histamine release by decreasing intracellular calcium content via inhibiting not only IP 3 or GTP-induced calcium release from ER but also calcium uptake into compound 48/80-treated RPMC. 25, 27) PCA represents one model of acute allergic reactions in which mast cells appear to be essential.
12) ABWE significantly inhibits anti-DNP IgE-mediated PCA. The mechanism of the protection against anti-DNP IgE has been suggested in part by the activity of ABWE to inhibit several protein tyrosine kinases in RPMC. Alternatively, ABWE may antagonize the effects of chemical mediators. Therefore, the protective mechanism of ABWE remains to be further studied.
In summary, the results from this study demonstrate the evidence that ABWE inhibits the immediate-type allergic reactions in experimental murine models. Therefore, we suggest that ABWE has a potent anti-allergic effect. However, further work should be directed toward the purification and identification of active constituents of Agaricus blazei. In addition, further studies are needed to elucidate the possibility that ABWE may also be effective in the human mast cell and in the treatment of human allergic disorders.
